CD 14 — AR226-1068a

EPA administrative record segment: CD-14--AR226-1068a (1,777 documents).

Page 16 of 18 — 1,777 documents
Title / Summary Year AR226 Docket Hash ID Pages
This is a final report from EnviroSystems Division of Resource Analysts, Inc. (Study Number 90171-3) detailing the static acute toxicity of FX 3820 to the daphnid, Daphnia aqua, conducted for 3M Company over 88 hours in December 1990. AR226-0119 K6rJ59VxodNVDBr0N3JoDV2mr 17
The document reports on an acute oral toxicity study conducted by 3M Company on a material identified as T-2297CoC, which found that the LD50 in rats is greater than 0.05 gm/kg but less than 1.5 gm/kg, with observable symptoms at the higher dosage. AR226-0126 zopMwyXn8Z5gdrJz2gvb1MRwg 2
The document reports on the acute toxicity of the substance FH 3820 to the alga Seleoastcum capricomutua, revealing a 96-hour EC50 of 255 µg/L and a no observed effect concentration of 125 µg/L. AR226-0122 jgByjeYOYa9p8BQ2aQrw3Jn9Z 25
The document is a final report prepared for 3M Corporate Toxicology detailing a study on unscheduled DNA synthesis in rat liver primary cell cultures induced by PFOS, conducted by Covance Laboratories and compliant with EPA Good Laboratory Practice regulations. AR226-0132 9J68GMY87oGO62Rm91epQL9q6 36
The document is a final report from Covance Laboratories on a Salmonella-Escherichia coli mammalian-microsome reverse mutation assay conducted with PFOS, prepared for 3M Corporate Toxicology, indicating compliance with EPA Good Laboratory Practice regulations. AR226-0133 YjEdxb47r2G9NX6GmJb90g0dV 43
This study report from the Centre for Xenobiotic Research investigates the levels of palmitoyl-CoA oxidation in frozen liver samples from 3M, specifically analyzing the effects of PFOS at a dosage of 20ppm, which resulted in a statistically significant increase in oxidation activity compared to the control group. AR226-0143 wgmv69GMwm82gm96M8bY16qjJ 9
This document reports on a study conducted by 3M to investigate the effects of PFOS exposure during gestation on perinatal mortality and respiratory function in rat pups born to PFOS-exposed dams. AR226-1104 8VG5jDv07XGev12mJ98q24D7d 23
This document reports on an acute toxicity test of a mixture containing perfluorooctanesulfonate (PFOS) on rainbow trout, indicating a 96-hour LC50 value greater than 400 mg/L, suggesting low toxicity at the tested concentrations. AR226-0715 Oz3e53dQo9VzyYMJmZZyr4wxv 4
This is a laboratory report from 3M Toxicology Services detailing the methodology and clinical information for a 48-hour fecal urobilinogen analysis, with specific notes on specimen collection and interpretation of results. AR226-0148 vV8pX3Yo5NEVyKj73Nxz9GBq9 26
This interim report presents preliminary data from a 26-week toxicology study on PFOS conducted in Cynomolgus monkeys by Covance for 3M, indicating that PFOS levels generally increased across all dose groups throughout the study duration. AR226-0151 VG79ayeD4VZjB2k27gL0JRvZN 18
The document outlines a study protocol by 3M to evaluate the cytotoxicity of four test articles (T-6292, T-6293, T-6294, T-6295) using hepatocytes from rats, with the aim of determining suitable concentrations for further in vitro metabolism studies. AR226-0161 XzorrkDv8G9637Jq04dJ0MkMy 19
The document discusses the metabolism of perfluorosulfonamide compounds in rat versus human hepatocytes, highlighting the detection of metabolites from the compound FX-12 (IX) and referencing a more sensitive analytical method used in the study. AR226-0164 KJKdBGw15Dyj1M5MQad971NEQ 1
The report by Kendall B. Wallace, Ph.D., investigates the effects of six perfluorooctanonyl compounds (PFCs) supplied by 3M on mitochondrial bioenergetics in isolated rat liver mitochondria, finding that all compounds inhibited ATP synthesis through various mechanisms affecting mitochondrial function. AR226-0166 wDjk6wQ2L4BpBgep9o080MEjV 10
The document discusses a study on the effects of perfluorinated arylalkylsulfonamides on the bioenergetics of rat liver mitochondria, specifically measuring mitochondrial membrane potential and respiration, supported by a grant from The 3M Company. AR226-0167 XRrNXLnq9bVMJ7jYJN6NdV4kd 34
The document summarizes a study on the effects of various perfluorinated compounds (PFCs), specifically highlighting that the sulfonamide PF95M is a potent uncoupler of mitochondrial bioenergetics, with an IC50 of approximately 1.5 µM, raising concerns about its potential health impacts if bioaccumulated. AR226-0169 8RrvrvMGkDaDvxZ0wY4byEyDK 3
This document is a composite report from 3M Environmental Laboratory detailing the results of analyses of human sera samples for fluorochemical compounds, including PFOA and PFOS, collected between March and April 1998, with an emphasis on the data's immediate relevance to human health concerns despite not adhering to Good Laboratory Practices. AR226-0178 8584YKK2ggR3q02mNa6eKj2RB 66
The document outlines a study protocol from 3M's Strategic Toxicology Laboratory aimed at isolating liver sub-cellular fractions and quantifying perfluorooctane sulfonate (PFOS) contents to investigate its effects on serum cholesterol levels and liver function. AR226-0181 qkj0n1pZOm3YMnM2ayDOyyxKM 6
This is a letterhead cover page from an unspecified organization, with no analytical content retained in the OCR. AR226-1111 zbz4q03a1RpQ2KrEXDn0e0zpa 3
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under Section 14 of the Toxic Substances Control Act. AR226-1118 rpyR7RpxY6mowQ8pLqLnXYqer 1
This is a TSCA NCIC Notification Form indicating that the referenced document contains confidential business information protected under Section 14 of the Toxic Substances Control Act. AR226-1119 3QeEyEaR60pRbKragbqOvdNZx 1
This document reports on a biodegradation test of a mixture containing 0.92% perfluorooctanesulfonate (PFOS) conducted by Pace Laboratories for 3M Company, noting significant Chemical Oxygen Demand (COD) and Biochemical Oxygen Demand (BOD) results but lacking detailed methodology and conclusions. AR226-0806 d0QoJrExY5y4qoJrkyVXomyb 5
This document contains estrous cycle data for multiple animal groups, detailing the number of days in estrus, diestrus, and proestrus, along with mean cycle lengths and the number of cycles observed. AR226-1126 mqVd3Nk76KaV0xLRgp7j8R9vg 18
The document is a request for a Science Advisory Board (SAB) review of a preliminary risk assessment of Perfluorooctanoic acid (PFOA) by the Office of Pollution Prevention and Toxics (OPPT), highlighting concerns about its potential systemic toxicity and carcinogenicity. AR226-1129 DDMYLRbaeJrpK0m6xe1E61VEM 3
The document reports that the 96-hour LC50 for a mixture containing perfluorooctanesulfonate (PFOS) and other components, referred to as FC-780, was greater than 5000 mg/L, indicating low acute toxicity to the fish species Fundulus heteroclitus. AR226-0869 g23b67ar8w6a9pGB81L7zD9pa 3
The document reports on biodegradation studies of a mixture containing perfluorooctanesulfonate (PFOS) as part of FC-780B, submitted by 3M Company, indicating that while the majority of the product components are readily biodegradable, no reliable conclusions can be drawn regarding the degradation potential of the fluorochemical component. AR226-0870 MJoqwGgxX39OemvzzEdJe5xZk 36
This is a letterhead cover page from an unspecified laboratory, with no analytical content retained in the OCR. AR226-0289 9JMQKn61n9bnoL3ZgV4eZ3XeR 7
The document reports on a guinea pig maximization study conducted by Hazleton Laboratories to assess the acute toxicity of a test substance (sample T-3609) for Minnesota Mining and Manufacturing, detailing the methodology and animal care involved in the study. AR226-0307 ymM0Kvpdo9YKx4qXnR1EVonvE 23
The document is a Quality Assurance Certificate for a mutagenicity testing study of 2-[N-ethyl-N-perfluoroalkyl(C=1~8) sulfonylamino] ethylacrylate conducted by BML, Inc., confirming compliance with Japanese standards and the accuracy of reported results. AR226-0309 2jqKgen1MQ2zNkGgkYq4G18zb 16
The document reports on a guinea pig maximization study conducted by Hazleton Laboratories for U.C. McCormick Minnesota Mining and Manufacturing, focusing on determining the irritant dose levels of a test material, potentially related to PFOA or PFOS, through topical application in young adult male albino guinea pigs. AR226-0315 kDaNDr8eLQ6y08DkBRx4R63vJ 22
The document reports on an in vitro mammalian cell gene mutation test evaluating the mutagenic activity of T-5869, a substance produced by 3M Belgium, conducted in compliance with Good Laboratory Practice standards. AR226-0319 06BkZvXwNNpeQKjEbwyQL6JDR 22
This document is a draft report for a 13-week dietary toxicity study of N-Methyl Perfluorooctanesulfonamido Ethanol (N-MeFOSE, T-6314) conducted by Covance Laboratories for 3M, detailing the study's context, personnel, and timeline. AR226-0300 zbjREMbDwLK7j5bZbez6pXLp6 554
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under Section 14 of the Toxic Substances Control Act. AR226-0930 DG4BZvrjGMbEEdJYRzOQn552o 1
Unreadable document. AR226-1142 ExrNQvzVpx4yVVy8L8jJXdpbN 1
This document is a final report on a cross-sectional study that measured levels of PFOA and six other fluorochemicals in the serum of 645 American Red Cross blood donors across six U.S. regions, utilizing high-pressure liquid chromatography/electrospray tandem mass spectrometry for analysis. AR226-1137 aNkLZVGMNgNg2bMbwp8wxYZ9 302
Unreadable document. AR226-0937 NE4mrZmkdeBXQ4Zo4ZJE4mE98 2
Unreadable document. AR226-0939 q0KOx8Ey31R2617rgODEXRLK 2
The document outlines a meeting between the EPA and the Fluoropolymer Industry to discuss the safe manufacture and use of fluoropolymers, specifically focusing on fluorinated processing aids like APFO/PFOA, while addressing regulatory actions and industry safety practices. AR226-0938 RaaYnr90wkXLJk1ww558dVQLv 7
Unreadable document. AR226-0942 dQJmz1rKrxKbpbmyakyERR5L5 1
The document summarizes studies conducted by 3M on the foaming characteristics of their AFFF products containing PFOS, focusing on their impact on wastewater treatment processes and the effectiveness of anti-foaming agents. AR226-0926 M4o8debJneQd4JEpKjEbe4Nrj 59
Unreadable document. AR226-0944 rwNQYbXVKnjEn6gjM1KZgLDJ 2
This is a final report from 3M Toxicology Services (HWI Number: 40200468) detailing an acute oral toxicity study of the test material T-5898 in rats, conducted according to OECD guidelines. AR226-0323 G5ZxzVEd9yz8VQd52G4Rvy9yY 24
This is a final report from 3M (HWI Number: 40200469) detailing a primary dermal irritation/corrosion study of the test material T-5898 conducted on rabbits, following OECD guidelines. AR226-0325 dQ9wV1D3YE72kJO4p3DMrL64R 11
This draft report details a 5-daily dose dermal absorption/toxicity study of the substance T-6684, sponsored by 3M, conducted on rabbits at Covance, with a completion date of July 11, 1997. AR226-0327 NExgZBMgOYDB1M8jr9BmknBZQ 53
This document appears to be a laboratory report cover page related to the analysis of PFOSA, with references to various lot numbers and purity percentages, but lacks substantial analytical content. AR226-0331 jm5X0ze2kp57xMmevVy1x8BRO 7
The document is an analytical report from 3M Environmental Laboratory detailing a comparative analysis of fluorochemicals, including PFOA and PFOS, in commercially obtained human serum samples, conducted under study identification number E02-1053. AR226-1150 8VDBNRXVBBoOppZ7Op9zDm3dZ 52
This summary report outlines the findings from a 104-week dietary toxicity and carcinogenicity study of Perfluorooctane sulfonic acid potassium salt (PFOS; T-6295) in rats, conducted by Covance Laboratories, detailing the study's design and preliminary observations through Week 53. AR226-0956 wD9wON7y1naxrV9Y1RddEzN5D 216
This document outlines a method for analyzing potassium perfluorooctanesulfonate (PFOS) and other fluorochemical surfactants in serum extracts using HPLC-electrospray/mass spectrometry, detailing the applicable compounds and matrices for testing. AR226-0025 2qj3D4e2a5QOxjawr8r7qyzkg 9
The document is a technical report summary from 3M detailing the analytical methodology and support for the fate of fluorochemicals, specifically focusing on sorption-desorption studies of radiolabeled fluorinated compounds, including FC-95 and FC-143, in soil. AR226-0360 yr8doyXKJjQbzjBooKM9VmDN6 3
The document details an experiment conducted by Bio/dynamics Inc. to assess the acute inhalation toxicity of a dust form of T-2307 CoC, received from the Minnesota Mining and Manufacturing Company, using Sprague-Dawley rats as test subjects. AR226-0964 v6a2B2ZaKX3dE4B5g5pmEoE6q 9
This is a Composite Analytical Laboratory Report from 3M detailing the quantitative analysis of fluorochemicals in environmental samples, encompassing multiple report numbers and analytical studies initiated between August 1999 and March 2000. AR226-0962 KGnwqr698Zryko6gJx5peYxLN 133
This document reports on a study conducted by 3M Company to estimate the log Pow (octanol-water partition coefficient) for the substance MeFOSEA, using HPLC methods in accordance with OECD guidelines. AR226-0381 RpYOjv1a99q9pp6ZDGzLDGq8E 17
The document outlines a study design for a 3M Microbial Metabolism Program aimed at optimizing conditions to enrich microbial populations capable of metabolizing fluorochemicals, including PFOA and PFOS, through various complex screening systems. AR226-0185 k96BgaJGaLeqM7jN0pV2D99gJ 13
This is a cover page for the book "Fluorinated Surfactants and Repellents" by Erik Kissa, published by Marcel Dekker, Inc., detailing various aspects of fluorinated compounds, including their structure, synthesis, properties, and environmental impacts. AR226-1267 b52X2n7MKZvjYEZxbkKQEzrz0 7
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under the Toxic Substances Control Act. AR226-1268 91BdxgR8pneEE4BN4yNvVmazD 1
The document discusses voluntary actions taken by Asahi Glass Fluoropolymers USA to evaluate and control emissions of ammonium perfluorooctanoate (PFOA) at their Bayonne, New Jersey site. AR226-1269 byzzgYEEQ2B0zyaoj0Z4rwoK6 1
The document discusses the Telomer Research Program's investigation into the biodegradation potential of 8-2 Telomer B Alcohol, a fluorotelomer intermediate, highlighting its physical-chemical properties and the challenges in testing due to its low water solubility and volatility, while also detailing the preparation of radiolabeled variants for quantitative studies. AR226-1283 x68Oeg1jzbZrBLyjkq0RjzM0 2
The document is a final report from the Kurume Laboratory Chemicals Evaluation and Research Institute in Japan, sponsored by Asahi Glass Co., Ltd., detailing a bioconcentration test of 2-perfluorooctyl ethanol (Test substance number K-1518) in carp, conducted in compliance with Good Laboratory Practice standards. AR226-1276 pmy7VwJ582qRg1GVnRKVvaGNB 94
This document appears to be comments from the Ohio Environmental Protection Agency regarding water contamination issues related to C-8, discussing escalating safe level standards and screening levels for PFOS/PFOA. AR226-1164 YGegEr44MzDMbDVm9z017Jkpn 19
This document appears to be a summary of various toxicity and environmental studies related to telomer manufacturing processes, including acute and chronic toxicity tests, biodegradation studies, and physicochemical property analyses, with references to DuPont submissions and interim reports. AR226-1293 37kJ2vQnKEo8yxMzZdMV5LMEn 1
Unreadable document. AR226-1296 X7MD4bYBxea1e6LeGbqjBaypy 1
Unreadable document. AR226-1297 wD0271pDmeqV6RwQ4rZ5qN1e6 1
This is a presentation from the APFN Work Group to the EPA, outlining the group's mission, membership, and ongoing efforts related to the safe manufacture and use of fluoropolymers, including the evaluation of APFN as a polymerization aid. AR226-1298 x19KrKEOjxBw0rqJkYZqR3x70 10
This document appears to be a meeting agenda from an EPA discussion on potential routes of exposure related to PFOA/PFOS, dated February 6, 2003. AR226-1300 reMZ9n236BNawkazVBDKaxzEe 5
Unreadable document. AR226-1301 4vovxEYe0NOO1NX3Z1DVNMGe 2
This is a presentation from the Telomer Research Program by Asahi Glass Company for the US Environmental Protection Agency, dated April 3, 2003, outlining the agenda and topics related to PFOA analysis and biodegradation studies. AR226-1302 Lg1M8E3yewY31wo5M34bJQ4wQ 42
This is a letterhead cover page from an unspecified organization, with no analytical content retained in the OCR. AR226-1307 k9XBLjngbOv0zmO5Nd2qLRXpB 4
The document is a confidential epidemiology surveillance report by DuPont detailing cancer incidence and mortality among employees at the Washington Works facility from 1956 to 1993, comparing observed cases and deaths to expected rates. AR226-1307 7O0NqOzngdZa5eedYdppMgvkR 15
The document discusses the mechanics of film formation in aqueous film-forming foam (AFFF), highlighting the role of fluorocarbon surfactants in creating a low surface tension that enhances fire extinguishing efficiency and burnback stability on volatile hydrocarbons and fuels. AR226-1314 DDrXEweRZ1QDK4k2E98yj8rLo 1
This is a TSCA NCIC Notification Form regarding confidential business information (CBI) documents, emphasizing the protection of such information under the Toxic Substances Control Act. AR226-1320 wDyGzmpJ63YGOy5O1waZjznN3 1
This document is a report on an acute eye irritation/corrosion study conducted on the substance T-7809 in rabbits, compliant with GLP standards and audited by NOTOX B.V. in the Netherlands. AR226-1323 vy2O9mQL3dg69JMEepb5Dm2rY 10
The document reports on an acute toxicity study of the substance T-4127 conducted on Daphnia magna, ensuring compliance with OECD Good Laboratory Practice and relevant U.S. regulations. AR226-1336 m62DzYzzEGv1o05XqeOD4Zq0 21
The document reports on a 96-hour acute toxicity study conducted on zebra fish using the substance T-4127, ensuring compliance with GLP standards and relevant regulatory guidelines. AR226-1335 0g9qXpbwZzvd7xvzeYEe3EnXM 38
The document reports on a 96-hour fresh water algal growth inhibition test conducted by NOTOX B.V. on the substance T-4127, ensuring compliance with OECD Good Laboratory Practice and relevant EPA regulations. AR226-1337 dYZx9B9EpRyQZ4MdbLvrENg70 37
The document reports on a range-finding study of 8-2 Telomer B Alcohol in rats, indicating that administration at 125 mg/kg/day resulted in significant decreases in body weight and increases in liver and kidney weights, with subsequent analyses planned for PFOA and PFNA levels. AR226-1340 G6BJzwwB7kaELjg43a1ygRqRn 34
This is a final report from Resource Analysts, Incorporated detailing the acute toxicity of FC-120 to the fathead minnow (Pimephales promelas), conducted for 3M Company over a 96-hour period in March 1992. AR226-0383 OzGxLjx84XEeY20JNG216EZpv 16
This laboratory report from 3M details an exploratory 28-day oral toxicity study in rats assessing the effects of PFOS and other perfluorinated compounds, with specific dosing levels and recovery periods for the test animals. AR226-0951 zbx9Vxjv20NJyDBxrmRY6m8va 295
The document is a draft report of a 26-week capsule toxicity study on Perfluorooctane Sulfonic Acid Potassium Salt (PFOS) conducted in Cynomolgus monkeys, prepared for 3M by Covance Laboratories. AR226-0958 7MjJn43gezMk96VERy3oBxmwj 438
The document reports on an acute oral toxicity study of the fluorochemical FC-143, produced by 3M Company, which determined the LD50 values in male and female rats to be 680 mg/kg and 430 mg/kg, respectively. AR226-0419 NG1exmDDXJzqBgRwD0omwM6kR 13
The document reports on a 28-day oral toxicity study of FC-143, a perfluorinated compound from 3M Company, which found that mice fed concentrations of 1,000 ppm or more experienced high mortality rates and significant adverse health effects, including reduced body weight and muscular weakness. AR226-0444 jmZO3EM57azGOvyp3EwnK56bR 17
The document is a final report on a primary eye irritation/corrosion study of the test material T-5898, conducted on rabbits to assess its irritative effects, in compliance with OECD guidelines. AR226-0969 QJYkZ3awqeGV6zM784ojE0874 22
The document is a report detailing a twenty-eight-day repeated dose oral toxicity study of a sample identified as D-1 in rats, conducted by Bio-Medical Research Laboratories Co., Ltd., focusing on the assessment of toxicity parameters. AR226-0968 ZJ5gOarpJqO1jgLbb0LRZ0ny0 219
3M is reporting to the EPA under TSCA Section 8(e) the draft results of a mortality study of workers at its Decatur, Alabama facility, which found no significant health risks associated with exposure to perfluorooctane sulfonate (PFOS). AR226-0980 qk1Mo8XVZrMpzKd78okrL0yqR 3
The document summarizes a technical report regarding the analysis of FC-95 levels in the serum and livers of monkeys from a subacute toxicity study (IRDC 137-092) conducted by 3M, highlighting that initial feeding levels were too high, resulting in the death of all test animals. AR226-0982 N285Z8mDMOYj5YyprNwXn35bp 3
This document is a TSCA 8(e) substantial risk supplemental notice from 3M regarding a two-year rat feeding study of N-Ethyl perfluorooctylsulfonamido ethanol (N-EtFOSE), which found a statistically significant increase in benign liver tumors in high dose female rats, corroborating earlier findings submitted to the EPA. AR226-0984 byE0MkR4KjYvqbYbX177dDYn1 3
The document is a technical report summarizing a 90-day subacute toxicity study of FM-3422, a perfluorinated compound, conducted on Rhesus monkeys, detailing dosage levels and findings related to serum and liver analysis. AR226-0985 M1gpVeoRyjanzLNwNB6e7YOk 4
3M submitted a TSCA 8(E) substantial risk notice to the EPA regarding N-Methyl Perfluorooctanesulfonamido Ethanol (N-MeFOSE), indicating that a 13-week dietary study in rats showed liver effects and reduced body weights at higher doses, consistent with toxicity observed in related perfluorooctanyl sulfonates. AR226-0988 OEQNDm94MzeeMdjmmB3BmK5eX 3
The document is an analytical laboratory report detailing the determination of the presence and concentration of Perfluorooctanesulfonate (PFOS) in liver and serum samples from a 26-week toxicity study conducted by 3M on Cynomolgus monkeys, compliant with EPA Good Laboratory Practice standards. AR226-0981 9LONEGqjOZ8B8885QKZYBDZaV 230
This document reports on a two-year oral toxicity and carcinogenicity study of fluorochemical FC-143 conducted by Riker Laboratories, Inc. for 3M Company, detailing various macroscopic and microscopic observations in rats, including findings of vascular mineralization and hepatocyte alterations. AR226-0438 G6V08EwVGv977j8Ewe9MEw8wq 312
The document is an analytical report by the 3M Environmental Laboratory detailing the determination of PFOS, M556, PFOSAA, and PFOSA concentrations in the liver and sera of rats exposed to EtFOSE-OH as part of a two-generation reproduction study. AR226-0987 Rpaw5BOxZ1ORxp4LnM604pVJk 130
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under Section 14 of the Toxic Substances Control Act. AR226-0994 m8DBdkGyVoX5XrBYDddd5LMg 1
This is a TSCA NCIC Notification Form indicating that the document is claimed as confidential business information under Section 14 of the Toxic Substances Control Act. AR226-0995 jyeMdEZZkpVJMKkLbq7qndBgQ 1
Unreadable document. AR226-0479 Ddy7NzYxaNXE1GYR03wykq3N5 2
The document provides a summary of various technical reports and laboratory studies conducted by 3M Environmental Lab on the environmental fate, transport, and biodegradation of PFOA and associated salts, including FC-143 and FX-1001, along with critiques from experts. AR226-0486 99orEL6Kz8abmmEoRgZnYM433 11
This is a 3M Strategic Toxicology Laboratory report (Study TLI 001525) detailing an acute inhalation limit test for perfluoroctanesulfonyl fluoride (POSF). AR226-1358 6RNg2V0rb4nqrydmYxnQVvXR 17
The document reports on an acute toxicity test of perfluorooctanoic acid ammonium salt (PFOA ammonium salt) on Daphnia magna, finding a 48-hour EC50 value of 126 mg/L based on nominal concentrations. AR226-0507 O1MLqj1w8791vgv8NYxM0O0RK 13
DuPont submitted study reports on 8-2 Telomer B Alcohol (CAS# 678-39-7) to the EPA for inclusion in Administrative Record 226, detailing findings from acute oral toxicity and mutagenicity assays without any claims of Confidential Business Information. AR226-1195 4J0ppm7QGkL82vbNYJX4bO8xj 2
The document provides a summary of ecotoxicity studies conducted on PFOA ammonium salt (FC-143) by 3M Environmental Laboratory between 1977 and 1979, detailing various tests on aquatic organisms and noting the substance's purity and composition. AR226-0528 OzLpmGvLy1DZo6x3XmOeGJMJe 13
The document reports on a study conducted by 3M Chemicals on the metabolism of N-Ethyl Perfluorooctane Sulfonamido Ethanol (Net-Fose; T-6316) in Cynomolgus monkeys after a single capsule dose, completed by Covance Laboratories. AR226-0532 O1ERYjXgbq5KXj7MwExpjv7bL 79
The document details a toxicity test of perfluorooctylsulfonate (PFOS) on the aquatic plant species Selenastrum capricornutum, conducted by AScI Corporation, which involved a 96-hour exposure to a mixture of the test substance in water, with nominal concentrations reported and various environmental parameters monitored. AR226-0536 yqgawgo8k2KZZaMMEVLVGoJE 13
The document details a toxicity study of perfluorooctylsulfonate (PFOS) conducted on the aquatic plant species Selenastrum capricornutum, using a test sample produced by 3M, which was assessed for its impact on algal growth over a 96-hour exposure period. AR226-0537 wqxnVgGyD9k29yXK9KOvZOeMQ 14